SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 145 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $4,169,000 | +226.0% | 219,415 | +181.3% | 0.69% | +203.1% |
Q4 2017 | $1,279,000 | -60.0% | 77,999 | -63.4% | 0.23% | -46.1% |
Q3 2017 | $3,195,000 | +225.7% | 213,027 | +91.1% | 0.42% | +162.3% |
Q2 2017 | $981,000 | +14.1% | 111,486 | +18.4% | 0.16% | +44.6% |
Q4 2015 | $860,000 | -8.0% | 94,183 | +53.8% | 0.11% | -36.7% |
Q2 2014 | $935,000 | -34.5% | 61,248 | -22.4% | 0.18% | -31.1% |
Q1 2014 | $1,427,000 | +2.8% | 78,938 | -21.0% | 0.26% | +3.6% |
Q4 2013 | $1,388,000 | – | 99,893 | – | 0.25% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alexandria Capital, LLC | 1,003,725 | $15,663,000 | 1.66% |
Golden State Equity Partners | 123,817 | $1,932,000 | 1.33% |
Rhenman & Partners Asset Management AB | 821,888 | $12,826,000 | 1.05% |
WASATCH ADVISORS LP | 10,072,381 | $157,180,000 | 0.77% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 29,636 | $462,000 | 0.73% |
Ceeto Capital Group, LLC | 80,000 | $1,248,000 | 0.63% |
EMC Capital Management | 48,992 | $765,000 | 0.58% |
Fort Sheridan Advisors LLC | 71,173 | $1,111,000 | 0.54% |
Vanguard Capital Wealth Advisors | 34,680 | $584,000 | 0.54% |
Casdin Capital, LLC | 1,080,000 | $16,853,000 | 0.50% |